生物
专家意见
抗菌剂
微生物群
细菌
人类健康
公认安全
生物技术
微生物学
医学
重症监护医学
生物信息学
食品科学
环境卫生
遗传学
作者
Ujjayni Saha,Sunil D. Saroj
标识
DOI:10.1080/14787210.2022.2128765
摘要
Lactobacilli are widely accepted as safe biological treatments and host immune modulators (GRAS- Generally regarded as safe) by the US Food and Drug Administration and Qualified Presumption of Safety. Understanding the molecular mechanisms of lactobacilli in the treatment and pathogenicity of bacterial infections can help with the prediction and development of innovative therapeutics aimed at pathogens which have gained resistance to antimicrobials. To formulate effective lactobacilli based therapy significant research on the effectiveness of different lactobacilli strains and its association with demographic distribution is required. Also, the side effects of such therapy needs to be evaluated.
科研通智能强力驱动
Strongly Powered by AbleSci AI